Please assess the completion status of the following clinical trial:

Trial Title: Highdose Nicotine Patch Therapy for Smokeless Tobacco Use

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. are at least 18 years of age and at most 55 years of age;~2. report daily ST use for the past 12 months;~3. identify ST as their primary tobacco product;~4. use an average of ≥ 3 cans/pouches per week;~5. are in general good health (determined by medical history and screening physical examination);~6. have been provided with, understand, and have signed the informed consent.~Exclusion Criteria:~1. are currently using (past 30 days) any other behavioral or pharmacologic tobacco treatment program;~2. are currently pregnant or lactating;~3. have had unstable angina, myocardial infarction, or coronary angioplasty within the past 3 months;~4. have a history of arrhythmia or an abnormal tracing on the baseline EKG;~5. have a blood pressure of greater than 140/90 or a pulse of more than 110 beats per minute;~6. have a history of severe skin allergies or dermatoses;~7. have a history of intolerance to nicotine patches;~8. have another member of their household already participating in this study;~9. are taking a medication known to interact with nicotine (i.e., clozapine);~10. are taking any prescription medication for depression or asthma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Active (Type: ACTIVE_COMPARATOR): 2 nicotine patches each at 21 mg/day for a total of 42 mg/day for 8 weeks
- placebo (Type: PLACEBO_COMPARATOR): 2 patches (containing non active ingredients) per day for 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).